SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Roberto Ceravolo, Carlo Rossi, Eleonora Del Prete, Ubaldo Bonuccelli, A review of adverse events linked to dopamine agonists in the treatment of Parkinson’s disease, Expert Opinion on Drug Safety, 2016, 1

    CrossRef

  2. 2
    Brendon P Boot, Comprehensive treatment of dementia with Lewy bodies, Alzheimer's Research & Therapy, 2015, 7, 1

    CrossRef

  3. 3
    Kannayiram Alagiakrishnan, Current Pharmacological Management of Hypotensive Syndromes in the Elderly, Drugs & Aging, 2015, 32, 5, 337

    CrossRef

  4. 4
    Louis Kuritzky, Alberto J. Espay, Jeffrey Gelblum, Richard Payne, Eric Dietrich, Diagnosing and treating neurogenic orthostatic hypotension in primary care, Postgraduate Medicine, 2015, 127, 7, 702

    CrossRef

  5. 5
    Nicholas Holt, Gerry McKay, Miles Fisher, Fludrocortisone, Practical Diabetes, 2015, 32, 7
  6. 6
    C. K. Wu, A. D. Hohler, Management of orthostatic hypotension in patients with Parkinson's disease, Practical Neurology, 2015, 15, 2, 100

    CrossRef

  7. 7
    J. Belin, J.L. Houéto, T. Constans, C. Hommet, B. de Toffol, K. Mondon, Particularités gériatriques de la maladie de Parkinson : aspects cliniques et thérapeutiques, Revue Neurologique, 2015, 171, 12, 841

    CrossRef

  8. 8
    Christiana Ossig, Heinz Reichmann, Treatment Strategies in Early and Advanced Parkinson Disease, Neurologic Clinics, 2015, 33, 1, 19

    CrossRef

  9. 9
    K. Wenzel, Nicht motorische Symptome bei Morbus Parkinson, psychopraxis. neuropraxis, 2014, 17, 4, 23

    CrossRef

  10. 10
    Seyed-Mohammad Fereshtehnejad, Johan Lökk, Orthostatic Hypotension in Patients with Parkinson’s Disease and Atypical Parkinsonism, Parkinson's Disease, 2014, 2014, 1

    CrossRef

  11. 11
    Claudio L. Bassetti, Neurologic Aspects of Systemic Disease Part I, 2014,

    CrossRef

  12. 12
    A. C. L. Ong, P. K. Myint, L. Shepstone, J. F. Potter, A systematic review of the pharmacological management of orthostatic hypotension, International Journal of Clinical Practice, 2013, 67, 7
  13. 13
    Santiago Perez-Lloret, María Verónica Rey, Anne Pavy-Le Traon, Olivier Rascol, Emerging drugs for autonomic dysfunction in Parkinson's disease, Expert Opinion on Emerging Drugs, 2013, 18, 1, 39

    CrossRef

  14. 14
    Christoph Schroeder, Jens Jordan, Horacio Kaufmann, Management of Neurogenic Orthostatic Hypotension in Patients with Autonomic Failure, Drugs, 2013, 73, 12, 1267

    CrossRef

  15. 15
    Santiago Perez-Lloret, María Verónica Rey, Anne Pavy-Le Traon, Olivier Rascol, Orthostatic hypotension in Parkinson’s disease, Neurodegenerative Disease Management, 2013, 3, 4, 363

    CrossRef

  16. 16
    Naveed M. Malek, Katherine A. Grosset, David Stewart, Graeme J.A. Macphee, Donald G. Grosset, Prescription of drugs with potential adverse effects on cardiac conduction in Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 6, 586

    CrossRef

  17. You have free access to this content17
    J. J. Ferreira, R. Katzenschlager, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, A. Schapira, A. Berardelli, W. H. Oertel, Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease, European Journal of Neurology, 2013, 20, 1
  18. 18
    Brendon P. Boot, Eric M. McDade, Scott M. McGinnis, Bradley F. Boeve, Treatment of Dementia With Lewy Bodies, Current Treatment Options in Neurology, 2013, 15, 6, 738

    CrossRef

  19. 19
    Graeme JA Macphee, David A Stewart, Parkinson's disease: treatment and non-motor features, Reviews in Clinical Gerontology, 2012, 22, 04, 243

    CrossRef

  20. 20
    Supplement 4: Canadian Guidelines on Parkinson's Disease, The Canadian Journal of Neurological Sciences, 2012, 39, S4, S1

    CrossRef

  21. 21
    Horacio Kaufmann, Richard Malamut, Lucy Norcliffe-Kaufmann, Kathleen Rosa, Roy Freeman, The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale, Clinical Autonomic Research, 2012, 22, 2, 79

    CrossRef

  22. 22
    Jaime McDonald, Philippe Corbeil, Emmanuelle Pourcher, Balance Control Improves Following Replacement of Paroxetine with Venlafaxine and Levodopa in a Case of Microvascular Dementia, The American Journal of Geriatric Pharmacotherapy, 2011, 9, 2, 133

    CrossRef

  23. 23
    Avrom L. Kurtz, Daniel I. Kaufer, Dementia in Parkinson’s Disease, Current Treatment Options in Neurology, 2011, 13, 3, 242

    CrossRef

  24. 24
    Juan Carlos Martinez-Castrillo, Lydia Vela, Javier del Val, Araceli Alonso-Canovas, Nonmotor Disorders and Their Correlation With Dopamine, The Neurologist, 2011, 17, S9

    CrossRef

  25. 25
    Santiago Perez-Lloret, María Verónica Rey, Luca Ratti, Olivier Rascol, Pramipexole for the treatment of early Parkinson’s disease, Expert Review of Neurotherapeutics, 2011, 11, 7, 925

    CrossRef

  26. 26
    Klaus Seppi, Daniel Weintraub, Miguel Coelho, Santiago Perez-Lloret, Susan H. Fox, Regina Katzenschlager, Eva-Maria Hametner, Werner Poewe, Olivier Rascol, Christopher G. Goetz, Cristina Sampaio, The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease, Movement Disorders, 2011, 26, S3
  27. 27
    Anne Pavy-Le Traon, Gerard Amarenco, Susanne Duerr, Horacio Kaufmann, Heinz Lahrmann, Stephanie R. Shaftman, François Tison, Gregor K. Wenning, Christopher G. Goetz, Werner Poewe, Cristina Sampaio, Anette Schrag, Glenn T. Stebbins, Olivier Rascol, The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension, Movement Disorders, 2011, 26, 11
  28. 28
    Lindy D. Wood, Clinical Review and Treatment of Select Adverse Effects of Dopamine Receptor Agonists in Parkinsonʼs Disease, Drugs & Aging, 2010, 27, 4, 295

    CrossRef

  29. 29
    Santiago Perez-Lloret, Olivier Rascol, Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease, CNS Drugs, 2010, 24, 11, 941

    CrossRef

  30. 30
    Roberto Ceravolo, Carlo Rossi, Lorenzo Kiferle, Ubaldo Bonuccelli, Nonmotor symptoms in Parkinson’s disease: the dark side of the moon, Future Neurology, 2010, 5, 6, 851

    CrossRef

  31. 31
    Eduardo Tolosa, Joan Santamaria, Carles Gaig, Yaroslau Compta, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  32. 32
    Theresa A. Zesiewicz, Marian L. Evatt, Potential Influences of Complementary Therapy on Motor and Non-Motor Complications in Parkinsonʼs Disease, CNS Drugs, 2009, 23, 10, 817

    CrossRef

  33. 33
    Giovanni Mostile, Joseph Jankovic, Treatment of dysautonomia associated with Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, S224

    CrossRef

  34. 34
    Tanya Simuni, Kapil Sethi, Nonmotor manifestations of Parkinson's disease, Annals of Neurology, 2008, 64, S2
  35. 35
    Miguel Coelho, Joaquim Ferreira, Mário Rosa, Cristina Sampaio, Treatment options for non-motor symptoms in late-stage Parkinson's disease, Expert Opinion on Pharmacotherapy, 2008, 9, 4, 523

    CrossRef

  36. 36
    W. H. Oertel, A. Berardelli, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, J. J. Ferreira, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, Late (Complicated) Parkinson's Disease,